EUVIMEDEUVIMED entdecken
Open Access

TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine

Anisul Arefin iD, Jihye Kim iD, Manas Pratim Chakraborty iD, Silvia Martinelli iD, Betty Bai, Francis S Lee iD, Joshua Levitz iD

Science Advances · 01.05.2026 · 12 (18)

DOI: 10.1126/sciadv.aec1444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 01.05.2026. Verfasst von Anisul Arefin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Ketamine, Receptor, Metabotropic Glutamate 5, Receptor, trkB, Neuronal Plasticity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A complex ensemble of neuromodulatory receptors orchestrates the many forms of synaptic plasticity that drive behavioral state changes, but an understanding of how such receptors functionally interact is limited. Here, we find that the antidepressant action of ketamine is dependent on both the receptor tyrosine kinase, tropomyosin-related kinase B (TrkB), and the G protein–coupled receptor, metabotropic glutamate receptor 5 (mGluR5). mGluR5 amplifies brain-derived neurotrophic factor (BDNF)–driven signaling of TrkB, enabling synaptic potentiation via “signaling cross-talk,” while BDNF activation of TrkB drives mGluR5 endocytosis via “trafficking cross-talk,” impairing synaptic depression. These modes of cross-talk are enhanced by ketamine, which increases surface and postsynaptic levels of TrkB. Last, we find that an mGluR5 positive allosteric modulator can enhance both modes of cross-talk and boost the effects of ketamine. Together, these data unravel the intimate relationship between different classes of neuromodulatory receptors, revealing that receptor-receptor interplay can drive therapeutic action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineReceptor, Metabotropic Glutamate 5Receptor, trkBNeuronal PlasticityReceptor Cross-TalkSynapsesAnimalsSignal TransductionBrain-Derived Neurotrophic FactorHumans

Substanzen

KetamineReceptor, Metabotropic Glutamate 5Receptor, trkBBrain-Derived Neurotrophic Factor

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA.
  • Department of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.

ORCID-Profile: Anisul Arefin, Jihye Kim, Manas Pratim Chakraborty, Silvia Martinelli, Francis S Lee, Joshua Levitz

Förderung

  • NIMH NIH HHS
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • Burroughs Wellcome Fund
  • Pritzker Neuropsychiatric Disorders Research Consortium
  • The Monique Weil-Caulier Award

Zitieren

APA

Arefin, A., Kim, J., Chakraborty, M. P., Martinelli, S., Bai, B., Lee, F. S., & Levitz, J. (2026). TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine. Science Advances, 12(18). https://doi.org/10.1126/sciadv.aec1444

Vancouver

Arefin A, Kim J, Chakraborty MP, Martinelli S, Bai B, Lee FS, et al. TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine. Science Advances. 2026;12(18). doi:10.1126/sciadv.aec1444

BibTeX
@article{Arefin2026,
  author = {Arefin, Anisul and Kim, Jihye and Chakraborty, Manas Pratim and Martinelli, Silvia and Bai, Betty and Lee, Francis S and Levitz, Joshua},
  title = {TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {18},
  doi = {10.1126/sciadv.aec1444}
}
Kostenlos starten →